Overcoming M&A Challenges - Planning a Good Deal and Your Exit

BioCenter Industry Panel - Menlo Park, California

The past few years have seen a significant increase in merger and acquisition activity in the life sciences industry. Join this panel to hear M&A strategy perspective from the acquirer and the acquired, the investor, and the lawyer. You will learn: How to identify the good target buyer, and how to approach him; Valuation challenges and strategies; How to structure the deal; What to expect after the acquisition; What are the relative advantages of pursuing a M&A over other transactions; What are the risks and how to mitigate theses risks; How to plan a successful exit. Read more»

Burrill & Company - The Stem Cell Meeting

This conference will examine the up to date most critical scientific, policy and business issues facing stem cell research, medicine and investment. In collaboration with the leaders of the City of San Francisco and the California Institute of Regenerative Medicine, it brings together an international assembly of scientists, clinicians, policymakers and business leaders who share their vision and passion for the life sciences’ most promising field.

Burrill & Company - The Japan Biotech Meeting

The 5th Annual Japan Biotech Meeting is designed to help explore the opportunities in this growing market sector. It brings together world leaders in from science/technology, business, finance, as well as senior executives from pharmaceuticals, chemical, agricultural, and nutraceuticals (wellness) companies.

BioExec Institute

A UC Berkeley Center for Executive Development class in collaboration with the BioCenter & produced by Deloitte & Touche USA LLP

The BioExec Institute is an executive program delivered by leading industry experts for life sciences Directors and VP-level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry. Delivered by industry specialists, including Deloitte & Touche USA LLP leaders and BioExec Institute faculty and alumni, the Institute offers attendees six-days of interactive programming from October through December 2008, including three evening networking receptions. Participants will have unique opportunities to debate the strategies and tactics of business leadership within BioPharma and will complete the program with invaluable insight and powerful networks to help them deliver bottom-line value in this growing industry. Read more»

Burrill & Company - The Biotech Meeting at Laguna Niguel

This meeting is the premier industry conference exclusively for Chief Executive Officers of biotechnology companies. This year, the Biotech Meeting will be held at the Montage Resort & Spa in Laguna Niguel in Southern California.

Burrill & Company - The Indiana Life Sciences Forum

Indiana has a lot going for it: large pharmaceutical companies, such as the headquarters of Eli Lilly; research or manufacturing centers for Pfizer, Bayer, and Baxter Healthcare; a growing medical devices industry and top-ranked universities. Indiana businesses, academic institutions and government agencies are coming together with initiatives to put the state on the map in the rapidly evolving life sciences industry and become a leading life sciences corridor. To ensure that this becomes a reality the state has to leverage its research talent and effectively transfer technology from its universities, nurture small to midsize biotech companies and attract significant pools of private investment and venture capital.

ALLTHINGSMEDIA: Venture Capital Forum 2008

Co-hosted by Springboard Enterprises and the She Made It initiative from The Paley Center for Media, ALLTHINGSMEDIA: 2008 is a venture capital Forum showcasing investment-ready, highgrowth media companies led by women. The Forum program includes a recruiting, screening, training and coaching program involving media executives, investors, attorneys, industry experts, business development professionals, and seasoned entrepreneurs. The eight-month program
culminates in the Forum event on October 30, 2008 at which selected companies will present their business opportunities to angel, venture and corporate investors. Read more...

The Annual Burrill Personalized Medicine Meeting

This two-day event, which encompasses detailed discussions on the whole spectrum of personalized medicine – from prediction to prevention – provides attendees with a detailed “window” into the emerging personalized medicine world and challenges and opportunities that this new paradigm presents.

Aging… Aren’t we all? And yet science may be poised with interventions that could bestow years more of healthy life. Would this be a boon or a bane for rapidly aging populations of the developed world? How will advances in genomics, cell biology, nutrition, bioinformatics, and other disciplines change the course of aging in the 21st century? What economic consequences—and opportunities—await? And how will regulators behave (is death the only endpoint, or will there be intermediate measures)?

Join us for a conference that just might change the way you view the rest of your life.

12/11